Since its establishment in 2004, E-Da Hospital has adhered to the vision of becoming an international first class medical center. The strategic goals include the establishment of a first-rate medical education and translational research center as well as the development of advanced diagnosis and treatment technologies in order to provide high-quality medical care for our patients. Through our sustained effort to incorporate regenerative medicine, cell therapy, and artificial intelligence into our healthcare services, we aim at becoming a beacon of excellence for patients with severe or critical illnesses in Southern Taiwan.
Medical specialists recruited from major medical centers offer multifaceted holistic care-based medical services at E-Da Hospital with a strong emphasis being placed on medical counseling as well as the integration of basic and clinical medical sciences to develop cutting-edge medical appliances such as orthopedic and neural conduction devices. Our institute is also well-equipped with state-of-the-art medical instruments including the 6D Varian EDGE Radiosurgery System, Positron emission tomography–computed tomography (PET-CT), Leksell Gamma Knife® Icon™, 640-slice computer tomography (CT), Magnetic Resonance Imaging (MRI) scanner, Volumetric modulated arc therapy, and the VMAT (RapidArc radiotherapy) System to ensure delivery of the best medical care to our patients.
The E-Da Biobank is established in accordance with the "Human Biodatabase Management Regulations" of the Ministry of Health and Welfare, Taiwan. It mainly collects cancer specimens of research interest from E-Da Hospital and E-Da Cancer Hospital. We collect specimens from approximately 600 patients each year. By the end of 2020, statistical analysis identified the top ten specimens as oral cancer, colorectal cancer, blood cancers, lung cancer, liver cancer, breast cancer, esophageal cancer, brain cancers, gynecological cancer, and urinary system cancers. We collect samples including serum, plasma, buffy coat, bone marrow, frozen tissue, and paraffin blocks from cancer patients.
To ensure a high quality of our specimens, the standard operating procedures of the E-Da Biobank include regular sample testing and round-the-clock storage equipment monitoring. All patients are required to sign a “Biobank Participant inform consent” before providing their tissue samples and clinical information for biomedical research use.